Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Aug 25:6:234.
doi: 10.3389/fphys.2015.00234. eCollection 2015.

Does the sympathetic nervous system contribute to the pathophysiology of metabolic syndrome?

Affiliations
Free PMC article
Review

Does the sympathetic nervous system contribute to the pathophysiology of metabolic syndrome?

Marina C Dos Santos Moreira et al. Front Physiol. .
Free PMC article

Abstract

The metabolic syndrome (MS), formally known as syndrome X, is a clustering of several risk factors such as obesity, hypertension, insulin resistance, and dislypidemia which could lead to the development of diabetes and cardiovascular diseases (CVD). The frequent changes in the definition and diagnostic criteria of MS are indications of the controversy and the challenges surrounding the understanding of this syndrome among researchers. Obesity and insulin resistance are leading risk factors of MS. Moreover, obesity and hypertension are closely associated to the increase and aggravation of oxidative stress. The recommended treatment of MS frequently involves change of lifestyles to prevent weight gain. MS is not only an important screening tool for the identification of individuals at high risk of CVD and diabetes but also an indicator of suitable treatment. As sympathetic disturbances and oxidative stress are often associated with obesity and hypertension, the present review summarizes the role of sympathetic nervous system and oxidative stress in the MS.

Keywords: cardiovascular diseases; central nervous system; hypertension; insulin resistance; obesity.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Hypothetical diagram summarizing the relationship between the components of the metabolic syndrome.

Similar articles

Cited by

References

    1. Abboud F. M. (1984). The sympathetic nervous system in hypertension. Clin. Exp. Hypertens. A 6, 43–60. - PubMed
    1. Abdellaoui A., Al-Khaffaf H. (2007). C-reactive protein (CRP) as a marker in peripheral vascular disease. Eur. J. Vasc. Endovasc. Surg. 34, 18–22. 10.1016/j.ejvs.2006.10.040 - DOI - PubMed
    1. Alberti K. G., Zimmet P. Z. (1998). Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet. Med. 15, 539–553. - PubMed
    1. Angelico F., Alessandri C., Ferro D., Pignatelli P., Del Ben S., Fiorello S., et al. . (2006). Enhanced soluble CD40L in patients with the metabolic syndrome: relationship with in vivo thombin generation. Diabetologia 49, 1169–1174. 10.1007/s00125-006-0222-7 - DOI - PubMed
    1. Bahia L., Aguiar L. G., Villela N., Bottino D., Godoy-Matos A. F., Geloneze B., et al. . (2006). Relationship between adipokines, inflammation, and vascular reactivity in lean controls and obese subjects with metabolic syndrome. Clin. Sci. 61, 433–440. 10.1590/S1807-59322006000500010 - DOI - PubMed